Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Schäfer

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Mycoses|September 6, 2003
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects]Monika Schäfer-Korting
Handbook of Experimental Pharmacology|October 20, 2023
Looking to the Future: Drug Delivery and Targeting in the Prophylaxis and Therapy of Severe and Chronic DiseasesMonika Schäfer-Korting
Medizinische Monatsschrift Fur Pharmazeuten|July 5, 2003
[Pharmacology at the Free University of Berlin. The presentation of a chair in pharmacology and toxicology at the Free University of Berlin]Monika Schäfer-Korting
Pharmazie in Unserer Zeit|April 8, 2003
[Antimycotics]Ulrike Holzgrabe, Monika Schäfer-Korting
Pharmazie in Unserer Zeit|April 8, 2003
[A silver lining on the horizon: new antimycotics]Monika Schäfer-Korting, Ulrike Holzgrabe
Handbook of Experimental Pharmacology|September 7, 2020
How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug DevelopmentMonika Schäfer-Korting, Christian Zoschke
Pharmazie in Unserer Zeit|August 6, 2003
[Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment]Monika Schäfer-Korting, Hans-Christian Korting
Handbook of Experimental Pharmacology|March 11, 2010
Carriers in the topical treatment of skin diseaseHans Christian Korting, Monika Schäfer-Korting
Psychiatrische Praxis|July 9, 2002
[A modern Kaspar Hauser]Elmar Etzersdorfer, Monika Schäfer, Johannes Becker-Pfaff
Plos One|August 18, 2012
Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activationNada Charbaji, Monika Schäfer-Korting, Sarah Küchler
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Mycoses|September 6, 2003
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects]Monika Schäfer-Korting
Handbook of Experimental Pharmacology|October 20, 2023
Looking to the Future: Drug Delivery and Targeting in the Prophylaxis and Therapy of Severe and Chronic DiseasesMonika Schäfer-Korting
Medizinische Monatsschrift Fur Pharmazeuten|July 5, 2003
[Pharmacology at the Free University of Berlin. The presentation of a chair in pharmacology and toxicology at the Free University of Berlin]Monika Schäfer-Korting
Pharmazie in Unserer Zeit|April 8, 2003
[Antimycotics]Ulrike Holzgrabe, Monika Schäfer-Korting
Pharmazie in Unserer Zeit|April 8, 2003
[A silver lining on the horizon: new antimycotics]Monika Schäfer-Korting, Ulrike Holzgrabe
Handbook of Experimental Pharmacology|September 7, 2020
How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug DevelopmentMonika Schäfer-Korting, Christian Zoschke
Pharmazie in Unserer Zeit|August 6, 2003
[Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment]Monika Schäfer-Korting, Hans-Christian Korting
Handbook of Experimental Pharmacology|March 11, 2010
Carriers in the topical treatment of skin diseaseHans Christian Korting, Monika Schäfer-Korting
Psychiatrische Praxis|July 9, 2002
[A modern Kaspar Hauser]Elmar Etzersdorfer, Monika Schäfer, Johannes Becker-Pfaff
Plos One|August 18, 2012
Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activationNada Charbaji, Monika Schäfer-Korting, Sarah Küchler
Pageof 11